HeadInvest LLC’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.77M Sell
6,708
-133
-2% -$85.3K 0.77% 43
2025
Q4
$4.63M Sell
6,841
-170
-2% -$116K 0.92% 36
2025
Q3
$4.48M Sell
7,011
-165
-2% -$100K 0.93% 37
2025
Q2
$3.85M Sell
7,176
-1,384
-16% -$662K 0.82% 38
2025
Q1
$3.59M Sell
8,560
-212
-2% -$92.1K 0.7% 43
2024
Q4
$3.63M Buy
8,772
+143
+2% +$62.7K 0.68% 43
2024
Q3
$4.36M Sell
8,629
-15
-0.2% -$7.29K 0.81% 41
2024
Q2
$4.21M Buy
8,644
+113
+1% +$56.7K 0.83% 41
2024
Q1
$4.61M Sell
8,531
-172
-2% -$94K 0.9% 37
2023
Q4
$4.83M Sell
8,703
-763
-8% -$358K 1% 33
2023
Q3
$4.08M Sell
9,466
-32
-0.3% -$16K 0.89% 37
2023
Q2
$4.8M Sell
9,498
-153
-2% -$73.3K 1.03% 31
2023
Q1
$4.83M Sell
9,651
-955
-9% -$457K 1.06% 29
2022
Q4
$4.33M Buy
10,606
+66
+0.6% +$25.6K 0.97% 34
2022
Q3
$3.43M Sell
10,540
-1
-0% -$367 0.82% 40
2022
Q2
$3.7M Buy
10,541
+76
+0.7% +$31K 0.82% 41
2022
Q1
$5.72M Sell
10,465
-39
-0.4% -$20.5K 1.09% 27
2021
Q4
$6.92M Sell
10,504
-16
-0.2% -$10K 1.23% 23
2021
Q3
$6.54M Sell
10,520
-209
-2% -$140K 1.24% 25
2021
Q2
$6.78M Sell
10,729
-51
-0.5% -$28.2K 1.29% 23
2021
Q1
$5.27M Sell
10,780
-745
-6% -$373K 1.08% 33
2020
Q4
$5.76M Sell
11,525
-1,079
-9% -$483K 1.22% 27
2020
Q3
$4.96M Sell
12,604
-65
-0.5% -$24K 1.43% 24
2020
Q2
$4.18M Sell
12,669
-4,169
-25% -$1.21M 1.32% 27
2020
Q1
$4.08M Sell
16,838
-1,890
-10% -$493K 1.53% 24
2019
Q4
$4.89M Sell
18,728
-5,630
-23% -$1.48M 1.4% 28
2019
Q3
$6.62M Sell
24,358
-11,338
-32% -$3.16M 2.01% 9
2019
Q2
$9.83M Buy
35,696
+658
+2% +$162K 2.78% 5
2019
Q1
$7.83M Sell
35,038
-49,626
-59% -$10.2M 2.2% 7
2018
Q4
$15.7M Buy
84,664
+50,822
+150% +$10.4M 2.49% 5
2018
Q3
$8.45M Sell
33,842
-7,101
-17% -$1.72M 2.43% 6
2018
Q2
$8.92M Sell
40,943
-9,590
-19% -$1.98M 2.72% 4
2018
Q1
$9.67M Sell
50,533
-4,030
-7% -$744K 3.1% 4
2017
Q4
$8.53M Sell
54,563
-10
-0% -$1.57K 2.63% 5
2017
Q3
$9.07M Sell
54,573
-200
-0.4% -$31.6K 2.84% 5
2017
Q2
$8.84M Sell
54,773
-5,000
-8% -$812K 2.91% 5
2017
Q1
$9.24M Buy
59,773
+1,602
+3% +$221K 3.11% 4
2016
Q4
$6.82M Sell
58,171
-5,080
-8% -$580K 2.54% 3
2016
Q3
$7.4M Sell
63,251
-4,500
-7% -$474K 2.63% 6
2016
Q2
$6.29M Buy
67,751
+5,000
+8% +$429K 2.38% 8
2016
Q1
$4.92M Hold
62,751
1.92% 15
2015
Q4
$4.58M Sell
62,751
-779
-1% -$55.6K 1.85% 15
2015
Q3
$4.72M Buy
63,530
+100
+0.2% +$7.16K 1.89% 16
2015
Q2
$4.07M Buy
63,430
+2,200
+4% +$152K 1.51% 26
2015
Q1
$4.73M Sell
61,230
-7,000
-10% -$545K 1.7% 21
2014
Q4
$5.06M Buy
68,230
+30
+0% +$2.1K 2.02% 20
2014
Q3
$4.83M Buy
68,200
+15,668
+30% +$991K 1.93% 23
2014
Q2
$3.51M Hold
52,532
1.42% 32
2014
Q1
$3.19M Hold
52,532
1.37% 34
2013
Q4
$2.79M Sell
52,532
-5,000
-9% -$263K 1.18% 36
2013
Q3
$2.87M Sell
57,532
-150
-0.3% -$7.21K 1.25% 35
2013
Q2
$2.59M Buy
+57,682
New +$2.52M 1.14% 35

Other funds holding IDXX

HeadInvest LLC's IDXX Position: Q1 2026 in Review

HeadInvest LLC reduced its Idexx Laboratories (IDXX) stake by 1.9% in Q1 2026, selling an estimated $85.3K and leaving 6,708 shares worth $3.77M. The position accounts for 0.77% of the portfolio, ranked #43.

HeadInvest LLC first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $15.7M in Q4 2018. 1,312 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • HeadInvest LLC held 6,708 shares of Idexx Laboratories worth $3.77M as of Q1 2026.
  • HeadInvest LLC sold 133 Idexx Laboratories shares in Q1 2026, an estimated $85.3K.
  • Idexx Laboratories made up 0.77% of HeadInvest LLC's portfolio in Q1 2026, its #43 holding.
  • HeadInvest LLC first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • HeadInvest LLC's Idexx Laboratories position peaked at $15.7M in Q4 2018.
  • 1,312 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on HeadInvest LLC's 13F filing for Q1 2026, filed 15 May 2026.